Nonclinical Application Task Force
Mission: Promote use of in silico solutions to conduct smarter (3R’s) nonclinical studies
In silico applications simulate real-world scenarios using computational models rather than physical experiments. Adopting nonclinical in silico applications offers several advantages in various fields, as cost-effectiveness, time efficiency, reduced dependency on animal testing, flexibility and iterative testing, risk reduction, data-driven insights, or reduced environmental impact, amongst others.
The new Nonclinical In Silico Application task force is part of the In Silico Application (ISA) Working Group that aims to deploy in silicomethods downstream and design comprehensive solutions (process, access to research, software, hardware, humanware, possibly services) to allow any organization to time and cost effectively adopt and deploy in silico methods all along the development, registration and life cycle of the products.
The task force focuses on nonclinical applications and aims to promote use of in silico solutions to refine, reduce or replace non-clinical studies.
Goals
- Create an expert group among our members
- Compile and review existing in silico solutions to reduce and refine nonclinical studies (e.g., selection of appropriate animal model(s), endpoints, time-points)
- Promote in silico approaches to derisk nonclinical studies
- Investigate how in silico approaches can help to ease nonclinical to clinical translation
